151 related articles for article (PubMed ID: 31283215)
21. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.
Armour A; Cunningham SH; Gaze MN; Wheldon TE; Mairs RJ
Br J Cancer; 1997; 75(4):470-6. PubMed ID: 9052395
[TBL] [Abstract][Full Text] [Related]
22. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
Carlin S; Mairs RJ; McCluskey AG; Tweddle DA; Sprigg A; Estlin C; Board J; George RE; Ellershaw C; Pearson AD; Lunec J; Montaldo PG; Ponzoni M; van Eck-Smit BL; Hoefnagel CA; van den Brug MD; Tytgat GA; Caron HN
Clin Cancer Res; 2003 Aug; 9(9):3338-44. PubMed ID: 12960120
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
24. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
25. Norepinephrine Transporter as a Target for Imaging and Therapy.
Pandit-Taskar N; Modak S
J Nucl Med; 2017 Sep; 58(Suppl 2):39S-53S. PubMed ID: 28864611
[TBL] [Abstract][Full Text] [Related]
26. Discovery of dual targeting PEGylated BG-P
Ozen Karakus O; Godugu K; Mousa SA
Bioorg Med Chem; 2021 Aug; 43():116278. PubMed ID: 34157571
[TBL] [Abstract][Full Text] [Related]
27. CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (
Grand-Guillaume J; Mansi R; Gaonkar RH; Zanger S; Fani M; Eugster PJ; Beck Popovic M; Grouzmann E; Abid K
J Transl Med; 2023 Sep; 21(1):604. PubMed ID: 37679770
[TBL] [Abstract][Full Text] [Related]
28. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Défachelles AS; Cougnenc O; Carpentier P
Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
[TBL] [Abstract][Full Text] [Related]
29. Gene manipulation to enhance MIBG-targeted radionuclide therapy.
Mairs RJ; Fullerton NE; Cosimo E; Boyd M
Nucl Med Biol; 2005 Oct; 32(7):749-53. PubMed ID: 16243651
[TBL] [Abstract][Full Text] [Related]
30. Norepinephrine-Transporter-Targeted and DNA-Co-Targeted Theranostic Guanidines.
Kortylewicz ZP; Coulter DW; Han G; Baranowska-Kortylewicz J
J Med Chem; 2020 Mar; 63(5):2051-2073. PubMed ID: 31268317
[TBL] [Abstract][Full Text] [Related]
31. Anti-Prostate Cancer Activity of 8-Hydroxyquinoline-2-Carboxaldehyde-Thiosemicarbazide Copper Complexes by Fluorescent Microscopic Imaging.
Xie F; Peng F
J Fluoresc; 2017 Nov; 27(6):1937-1941. PubMed ID: 28653241
[TBL] [Abstract][Full Text] [Related]
32. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
Strickland DK; Vaidyanathan G; Friedman HS; Zalutsky MR
J Neurooncol; 1995; 25(1):9-17. PubMed ID: 8523094
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
Zhang H; Huang R; Pillarsetty N; Thorek DL; Vaidyanathan G; Serganova I; Blasberg RG; Lewis JS
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):322-32. PubMed ID: 24173571
[TBL] [Abstract][Full Text] [Related]
34. Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma.
Karakus OO; Godugu K; Rajabi M; Mousa SA
J Med Chem; 2020 Jul; 63(14):7653-7662. PubMed ID: 32571015
[TBL] [Abstract][Full Text] [Related]
35. Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination.
McCluskey AG; Boyd M; Pimlott SL; Babich JW; Gaze MN; Mairs RJ
Br J Radiol; 2008 Oct; 81 Spec No 1():S28-35. PubMed ID: 18819996
[TBL] [Abstract][Full Text] [Related]
36. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
37. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Cunningham SH; Mairs RJ; Wheldon TE; Welsh PC; Vaidyanathan G; Zalutsky MR
Br J Cancer; 1998 Jun; 77(12):2061-8. PubMed ID: 9649115
[TBL] [Abstract][Full Text] [Related]
38. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
[TBL] [Abstract][Full Text] [Related]
39. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
[TBL] [Abstract][Full Text] [Related]
40. Hyperbaric oxygen enhances the effects of meta-iodobenzylguanidine (MIBG) on energy metabolism and lipid peroxidation in the human neuroblastoma cell line SK-N-BE(2C).
Cornelissen J; Van Kuilenburg AB; Elzinga L; Van der Kleij AD; Voûte PA; Van Gennip AH
Anticancer Res; 1997; 17(1A):259-64. PubMed ID: 9066662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
